(A) RhoE mRNA is induced after tetracycline (tet) removal in EJ-p53 cells (tet-off). Total RNA was prepared from these samples and northern blots were performed sequentially using ³²P-labeled probe against RhoE, p21, and 36B4 (loading control). Total RNA was prepared from other p53 +/+ and -/- cell lines after mitomycin C (MMC, 1 μg/ml) or etoposide (ETO, 25 μM) treatment at the indicated times.
(B) U2OS and Saos2 cells were transfected with siRNA oligos targeting wt-p53 or luciferase control for 1 day, then treated with either 25 μM of ETO for 24 hr (U20S). or infected with adenovirus expressing p53 (Ad-p53) or Ad-GFP control (Saos2). Protein extracts were immunoblotted with RhoE, p21, p53 and β-actin antibodies.
(C) The p53 binding site at -2200 is responsible for RhoE transcription. Luciferase assay reporter gene constructs containing the putative p53-recognition sequences within the RhoE promoter were co-transfected into Saos2 cells with either wt-p53 or control expression constructs. U2OS cells were also transfected with the reporter plasmids, then treated with 600 nM camptothecin (CPT) for 24 hr. The reporter plasmids used were the: empty PGL3 vector, the full length (FL) promoter, six reporter constructs with p53-binding site mutations (M1-M6), and the p21 promoter was used as a control. The putative p53 recognition sequence within the RhoE promoter and the p53-consensus binding sequences (BS) are shown. Error bars represent the standard deviation from three independent experiments.
(D) Chromatin immunoprecipitation (ChIP) assay of p53 DNA binding to the RhoE promoter. Saos2 cells were infected with Ad-p53 or Ad-GFP for 24 hr, then ChIP was performed using either a p53 antibody or an HA-tag antibody (negative control). U2OS cells were also used for ChIP analysis of endogenous p53 activity upon DNA damage by 24 hr treatment with 600 nM CPT. Amplification products were 235 bp (RhoE) and 417 bp (p21), respectively.

(A) Expression of RhoE protein and mRNA in RhoE knockdown cells. RhoE expression was analyzed by northern and western blot analysis in U2OS cells transiently transfected with shRNA against RhoE (R1, R2) or control scrambled RhoE shRNA (C1, C2), then treated the following day with 600 nM CPT for the indicated times.
(B) RhoE effects actin stress fiber formation in response to genotoxic stress. U2OS cells stably transfected with RhoE shRNA (R1) or scrambled RhoE shRNA plasmids and were treated with CPT (600 nM) for 24 hr. Cells were stained for filamentous actin with rhodamine-conjugated phalloidin.
(C) RhoE depletion increases genotoxic stress-induced apoptosis. U2OS cells stably transfected with RhoE shRNA or scrambled RhoE shRNA plasmids were exposed to CPT (600 nM) or ETO (25 μM) for 24 hr. The M1 cell population represents the percentage of sub-G1 cells from each sample as calculated from 3 independent experiments. The percentages in the right panel indicate the number of apoptotic cells, which stain Annexin V positive and PI negative.
(D) DNA damage-induced cell blebbing is increased by RhoE knockdown. U2OS cells expressing control (scrambled) or RhoE shRNA plasmids were cultured on cover glass and treated with 600 nM CPT or DMSO for 48 hr then imaged by phase-contrast microscopy. Arrows indicate cells with membrane-blebbing. The percentage of cells that bleb at 32 hr were quantified and represents the mean ± S.E.M. of 3 experiments.

(A) Inhibition of RhoE expression enhances ROCK I kinase activity in wt-p53 expressing cells. U2OS cells stably expressing scrambled-RhoE-shRNA and RhoE-shRNA were treated with CPT for 12 or 24 hr. Cell lysates were subjected to immunoprecipitation (IP) with 2 μg of ROCK I antibody and western blotted to examine the levels of ROCK I and RhoE. The IP pallets were assayed for Rho kinase activity using MYPT1 as the substrate. The assay mixture was then subjected to SDS-PAGE. The gel was dried and autoradiographed. The band corresponding to MYPT1 was excised and quantified by scintillation counting. Error bars represent the standard deviation from three individual experiments.
(B) Effects of RhoE over-expression on ROCK I kinase activity in 293ET cells containing dysfunctional p53. 293ET cells were transfected with control and RhoE expression vector for 24 hr. The cells were then treated with 600 nM CPT for 24 and 32 hr, immunoprecipitated, and analyzed as described in (A).

(A) ROCK I activation/cleavage upon genotoxic stress. U2OS cells stably transfected with control (scrambled), ROCK I, or RhoE shRNA plasmids were treated with 600 nM CPT for 24 hr. The cleavage of ROCK I was assessed by immunoblotting with antibodies to both the C-terminus (top panel) and N-terminus of ROCK I (bottom panel). The cell lysates were further blotted for cleaved PARP, RhoE, p53, and β-actin.
(B&C) shRNA ablation of ROCK I expression inhibits the rate of apoptosis. U2OS (B) and HCT116 p53+/+ cells (C) expressing the shRNA plasmids were treated with 600 nM CPT for the indicated times. Apoptotic cell death was quantified by TUNEL assay and enumerated by flow cytometry. The left panel shows a representative experiment (B) and the percentage of TUNEL positive cells in the graphs is shown as the mean ± SEM (n=3).
(D) Effect of ROCK I inhibitor (Y-27632) on CPT-mediated apoptosis.
U2OS cells were treated with either DMSO or Y-27632 (3 μM) for 24 hr, and exposed to 600 nM CPT for the indicated time periods (24 and 48 hr). Cells were then assessed for apoptosis by TUNEL assay by both fluorescence microscopy and flow cytometry as described for (B&C).